%. CAS should not be performed in these
patients except as part of an ongoing clinical trial
(GRADE 1, Level of Evidence B).
8. There are insufficient data to recommend CAS as primary therapy for neurologically asymptomatic patients
with 70% to 99% diameter stenosis. Data from CREST
suggest that in properly selected asymptomatic patients,
CAS is equivalent to CEA in the hands of experienced
interventionalists. Operators and institutions performing